Finance

Lists
Q1 2027 earnings • in 1 day
See details
GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
၂,၆၅၁.၀၀ ₹
+၁.၅၄%
(+၄၀.၃၀) 1D
ဇူ ၃၁, GMT+၅:၃၀ ၁၅:၃၀:၀၂  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for GLAXO...
Open
၂,၆၁၇.၉၀ ₹
High
၂,၆၇၉.၀၀ ₹
Low
၂,၅၆၄.၇၀ ₹
Mkt. cap
ဋေ ၄.၄၉ သ
Avg. vol.
၈.၉၃ သောင်း
Volume
၁.၁၈ သိန်း
Dividend
၂.၁၅%
Quarterly dividend
၁၄.၂၅ ₹
Ex-dividend date
၂၀၂၆ မေ ၂၉
P/E ratio
၄၃.၃၅
52-wk high
၃,၁၉၈.၁၀ ₹
52-wk low
၂,၀၈၈.၁၀ ₹
EPS
၆၁.၁၅ ₹
Shares outstanding
၁၆.၉၄ ကုဋေ
No. of employees
၃ ထောင်
Open
၂,၆၁၇.၉၀ ₹
High
၂,၆၇၉.၀၀ ₹
Low
၂,၅၆၄.၇၀ ₹
Mkt. cap
ဋေ ၄.၄၉ သ
Avg. vol.
၈.၉၃ သောင်း
Volume
၁.၁၈ သိန်း
Dividend
၂.၁၅%
Quarterly dividend
၁၄.၂၅ ₹
Ex-dividend date
၂၀၂၆ မေ ၂၉
P/E ratio
၄၃.၃၅
52-wk high
၃,၁၉၈.၁၀ ₹
52-wk low
၂,၀၈၈.၁၀ ₹
EPS
၆၁.၁၅ ₹
Shares outstanding
၁၆.၉၄ ကုဋေ
No. of employees
၃ ထောင်
News stories
From sources across the web
Foreign Policy Journal
Foreign Policy Journal
·
ပြီးခဲ့သည့် ၃၈ မိနစ်
Palantir Technologies (NASDAQ: PLTR) Financials Defy "LLM Wrapper" Dismissal As Stock Retreats From Peak
TechStock²
TechStock²
·
ပြီးခဲ့သည့် ၄၆ မိနစ်
NANO Nuclear (NASDAQ:NNE) Closes Near 52-Week Low Even With $569 Million in Liquidity
Bloomberg.com
Bloomberg.com
·
ပြီးခဲ့သည့် ၉ နာရီ
Warsh’s Silent Treatment Has S&P Traders Bracing for Wild Swings
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
CEO-
Employees၃.၁ ထောင်
Founded၁၉၂၄ နို ၁၃
Headquarters-
Sector-
Next call in 32:04:42
ဩ ၃ တနင်္လာ, ၈:၄၅
Fiscal period
Q1 2027
EPS / Est. (INR)
- / ၁၃.၉၀ ₹
Revenue / Est. (INR)
- / ၉၁၁.၁၅ ဋေ
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
၈၀၅.၁၇ ဋေ
၉၇၉.၉၄ ဋေ
ဋေ ၁.၀၄ ထ
၉၉၅.၃၀ ဋေ
Cost of goods sold
၂၈၇.၇၁ ဋေ
၃၅၅.၅၃ ဋေ
၃၆၃.၈၂ ဋေ
၃၆၈.၅၆ ဋေ
Cost of revenue
၂၈၇.၇၁ ဋေ
၃၅၅.၅၃ ဋေ
၃၆၃.၈၂ ဋေ
၃၆၈.၅၆ ဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁၅၂.၅၇ ဋေ
၁၃၈.၀၅ ဋေ
၁၅၁.၈၈ ဋေ
၂၉၄.၆၈ ဋေ
Operating expense
၂၈၁.၇၈ ဋေ
၃၀၆.၁၁ ဋေ
၃၂၆.၄၂ ဋေ
၂၈၄.၁၇ ဋေ
Total operating expenses
၅၆၉.၄၉ ဋေ
၆၆၁.၆၄ ဋေ
၆၉၀.၂၄ ဋေ
၆၅၂.၇၃ ဋေ
Operating income
၂၃၅.၆၈ ဋေ
၃၁၈.၃၀ ဋေ
၃၅၁.၀၂ ဋေ
၃၄၂.၅၇ ဋေ
Other non operating income
၄၃.၇၂ ကုဋေ
၃၃.၅၇ ကုဋေ
၃၂.၁၂ ကုဋေ
-၁၀၉.၄၁ ဋေ
EBT including unusual items
၂၇၈.၉၈ ဋေ
၃၅၄.၀၀ ဋေ
၃၉၉.၉၃ ဋေ
၃၇၃.၁၀ ဋေ
EBT excluding unusual items
၂၇၈.၉၈ ဋေ
၃၅၁.၃၆ ဋေ
၃၈၁.၉၅ ဋေ
၂၉၃.၅၁ ဋေ
Income tax expense
၇၃.၉၇ ကုဋေ
၉၆.၅၁ ကုဋေ
၁၀၄.၃၁ ဋေ
၉၅.၂၄ ကုဋေ
Effective tax rate
၂၆.၅၁%
၂၇.၂၆%
၂၆.၀၈%
၂၅.၅၃%
Other operating expenses
၁၁၃.၆၉ ဋေ
၁၅၀.၆၃ ဋေ
၁၅၄.၂၂ ဋေ
-၂၃.၆၈ ကုဋေ
Net income
၂၀၅.၀၁ ဋေ
၂၅၇.၄၉ ဋေ
၂၉၅.၆၂ ဋေ
၂၇၇.၈၆ ဋေ
Net profit margin
၂၅.၄၆%
၂၆.၂၈%
၂၈.၃၉%
၂၇.၉၂%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
၆၅.၇၃ ကုဋေ
Interest expense
-၄.၂၀ သန်း
-၅.၁၀ သန်း
-၁.၁၉ ကုဋေ
-၆.၁၂ သန်း
Net interest expenses
-၄.၂၀ သန်း
-၅.၁၀ သန်း
-၁.၁၉ ကုဋေ
၆၅.၁၂ ကုဋေ
Depreciation and amortization charges
၁၅.၅၂ ကုဋေ
၁၇.၄၃ ကုဋေ
၂၀.၃၂ ကုဋေ
၁၃.၁၇ ကုဋေ
EBITDA
၂၄၅.၂၇ ဋေ
၃၃၄.၇၈ ဋေ
၃၆၀.၆၁ ဋေ
၃၅၂.၁၉ ဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google အက်ပ်များ